House Republicans proposed Medicaid cuts last month that would have disastrous financial consequences for hospitals, especially for those in rural areas. While the plan aims to reduce government ...
Arundhati Parmar is VP and Editor-in-Chief at MedCity News. In this role, she oversees MedCity's news coverage as well as develops the content for several conferences that the publication hosts.
Many experts - be they venture capitalists or private equity investprs - shared their advice to biotech entrepreneurs navigating a tough funding envornment.
Walgreens is selling itself to the private equity firm Sycamore Partners. This comes after the company has faced increased ...
ZeroEyes was founded in 2018 by a team of former Navy SEALs, noted Sam Alaimo, one of the company’s co-founders. He said the idea for the company came from its current CEO, Mike Lahiff.
A Beam Therapeutics gene-editing therapy designed to fix a mutation at the root of a rare liver protein deficiency now has early signs of efficacy along with safety data that ease some concerns ...
Rajesh Aggarwal, MD, PhD, FRCS, FACS is the Founder and CEO of twenty30 health, a care coordination platform for metabolic and obesity management for individuals and providers. He is also a ...
The use of AI in healthcare has evolved quite a bit over the past few years — with many healthcare organizations transitioning from a state of cautious experimentation to more serious attempts ...
For two years, an ambitious initiative in sub-Saharan Africa has demonstrated how pocket-sized ultrasound technology can help bridge the gap in maternal care access. The implementation of point-of ...
The Sunrise Group, a sleep company, has launched a women’s health program through its digital sleep clinic called Dreem Health, the company announced on Thursday. Belgium-based Sunrise offers a ...
Protein therapies for the eye must be dosed as frequent injections. Gene therapy offers one-time treatment, but must also be administered by injection. Neurotech Pharmaceuticals’ gene therapy ...